This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dr Reddy Laboratories Ltd (RDY)

NYSE: Health Care

Company Cash Flow
Mar 2015 Mar 2014 Mar 2013 Mar 2012
Cash Flow From Operating Activities
Net Income (Loss) 354.64M 359.47M 308.34M 0.00
Operating Gains/Losses -12.89M -7.42M -8.45M -4.05M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -174.37M 1.97M -116.53M -136.02M
(Increase) Decrease in Inventories -87.10M -66.36M -71.13M -85.50M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 879.45K -35.59M 33.91M 18.64M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 -101.77M -89.41M
(Increase) Decrease In Other Working Capital 20.10M -73.62M -87.87M 26.74M
Other Non-Cash Items 73.81M 28.04M 96.22M 401.96M
Net Cash From Continuing Operations 400.28M 325.23M 244.77M 317.49M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 400.28M 325.23M 244.77M 317.49M
Sale of Property, Plant & Equipment 2.75M 1.90M 5.84M 806.01K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -245.08M -177.58M -122.59M -166.35M
Acquisitions -4.41M 0.00 -32.09M 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 13.06M 16.43M 3.35M 6.53M
Cash Provided by Financing Activities
Net Cash From Investing Activities -366.23M -277.72M -256.29M -366.93M
Issuance of Debt 0.00 168.77M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 79.95K 33.42K 18.38K 117.95K
Repayment of Long-Term Debt -59.42M -3.46M 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends -57.36M -49.88M -49.88M -43.56M
Other Financing Charges, Net 50.85M -119.09M 16.93M 116.87M
Net Cash From Financing Activities -65.85M -3.63M -32.94M 73.43M
Effect of Exchange Rate Changes -17.08M 12.88M 1.73M 9.81M
Net Change in Cash & Cash Equivalents -48.88M 56.76M -42.73M 33.79M
RDY News

RDY Dr Reddy Laboratories Ltd

Chart of RDY

Analysts Ratings for RDY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0

RDY Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs